Philip N. Edwards

The preclinical pharmacology of “Arimidex” (Anastrozole; ZD1033) — a potent, selective aromatase inhibitor

Michael Dukes, Philip N. Edwards, M. S. Large et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 89 citations

Molecular Pharmacology, “ Arimidex ”, Biochemistry +11

Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors

G. C. CRAWLEY, Robert I. Dowell, Philip N. Edwards et al. · Journal of Medicinal Chemistry · 1992 · 84 citations · Full text

Pharmaceutical Science, Pharmacotherapy, New Series +16

Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening

João Neres, Mark L. Brewer, Laura Ratier et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 68 citations · Full text

Antiparasitic Agent, Medicine, Parasitic Protozoa +7

Aminoimidazolylmethyluracil Analogues as Potent Inhibitors of Thymidine Phosphorylase and Their Bioreductive Nitroimidazolyl Prodrugs

Philip Reigan, Philip N. Edwards, Abdul M Gbaj et al. · Journal of Medicinal Chemistry · 2004 · 47 citations · Full text

Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives:  Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase

Christian Cole, Philip Reigan, Abdul M Gbaj et al. · Journal of Medicinal Chemistry · 2002 · 45 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Anticancer Drug Design +13